CR20140362A - Fenilimidazopirazoles sustituidos y su uso - Google Patents

Fenilimidazopirazoles sustituidos y su uso

Info

Publication number
CR20140362A
CR20140362A CR20140362A CR20140362A CR20140362A CR 20140362 A CR20140362 A CR 20140362A CR 20140362 A CR20140362 A CR 20140362A CR 20140362 A CR20140362 A CR 20140362A CR 20140362 A CR20140362 A CR 20140362A
Authority
CR
Costa Rica
Prior art keywords
phenylimidazopirazoles
replaced
phenylimidazopirazoles replaced
Prior art date
Application number
CR20140362A
Other languages
English (en)
Spanish (es)
Inventor
Antje Kahnert
Frank Süssmeier
Michael Härter
Bernd Buchmann
Walter Hubsch
Mario Lovell
Klemens Lustig
Sylvia Grünewald
Joachim Telser
Hannah Jörissen
Mélanie Héroult
Niels Lindner
Original Assignee
Bayer Pharma AG
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47594775&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR20140362(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Pharma AG, Bayer Ip Gmbh filed Critical Bayer Pharma AG
Publication of CR20140362A publication Critical patent/CR20140362A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CR20140362A 2012-01-25 2014-07-28 Fenilimidazopirazoles sustituidos y su uso CR20140362A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12152515 2012-01-25

Publications (1)

Publication Number Publication Date
CR20140362A true CR20140362A (es) 2014-08-21

Family

ID=47594775

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20140362A CR20140362A (es) 2012-01-25 2014-07-28 Fenilimidazopirazoles sustituidos y su uso

Country Status (30)

Country Link
US (2) US20150005288A1 (enExample)
EP (1) EP2807162B1 (enExample)
JP (1) JP6101290B2 (enExample)
KR (1) KR20140117582A (enExample)
CN (1) CN104411707B (enExample)
AP (1) AP2014007869A0 (enExample)
AR (1) AR089788A1 (enExample)
AU (1) AU2013211707A1 (enExample)
BR (1) BR112014018450A8 (enExample)
CA (1) CA2862163A1 (enExample)
CL (1) CL2014001959A1 (enExample)
CO (1) CO7101244A2 (enExample)
CR (1) CR20140362A (enExample)
CU (1) CU20140096A7 (enExample)
DO (1) DOP2014000173A (enExample)
EA (1) EA201491427A1 (enExample)
EC (1) ECSP14010868A (enExample)
ES (1) ES2639338T3 (enExample)
GT (1) GT201400161A (enExample)
IL (1) IL233652A0 (enExample)
MA (1) MA35877B1 (enExample)
MX (1) MX2014008893A (enExample)
PE (1) PE20142421A1 (enExample)
PH (1) PH12014501687A1 (enExample)
SG (1) SG11201404118XA (enExample)
TN (1) TN2014000320A1 (enExample)
TW (1) TW201343649A (enExample)
UY (1) UY34590A (enExample)
WO (1) WO2013110590A1 (enExample)
ZA (1) ZA201405392B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2862163A1 (en) * 2012-01-25 2013-08-01 Bayer Pharma Aktiengesellschaft Substituted phenylimidazopyrazoles and use thereof
CA3280124A1 (en) 2013-07-31 2025-10-31 Avalyn Pharma Inc. Aerosol imatinib compounds and uses thereof
US20180368404A1 (en) 2014-11-06 2018-12-27 Basf Se 3-pyridyl heterobicyclic compound for controlling invertebrate pests
BR112018007034B1 (pt) * 2015-10-08 2022-10-11 Fmc Corporation Composto, composição, método para controlar uma praga de invertebrados e semente revestida
PY1974629A (es) * 2018-09-13 2021-01-11 Syngenta Participations Ag Compuestos de azol-amida pesticidamente activos
CN109096195A (zh) * 2018-09-27 2018-12-28 上海雅本化学有限公司 一种艾曲波帕的制备方法
KR20220082835A (ko) * 2019-10-16 2022-06-17 바이엘 악티엔게젤샤프트 1,1'-디술판디일비스(4-플루오로-2-메틸-5-니트로벤졸)의 제조 방법
BR112022015110A2 (pt) * 2020-01-29 2022-11-08 Foghorn Therapeutics Inc Compostos e usos dos mesmos

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0753730B2 (ja) * 1988-07-26 1995-06-07 三共株式会社 イミダゾピラゾール誘導体
UA80171C2 (en) * 2002-12-19 2007-08-27 Pfizer Prod Inc Pyrrolopyrimidine derivatives
US7419978B2 (en) * 2003-10-22 2008-09-02 Bristol-Myers Squibb Company Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors
KR101061599B1 (ko) * 2008-12-05 2011-09-02 한국과학기술연구원 비정상 세포 성장 질환의 치료를 위한 단백질 키나아제 저해제인 신규 인다졸 유도체, 이의 약학적으로 허용가능한염 및 이를 유효성분으로 함유하는 약학적 조성물
CA2765534C (en) * 2009-06-15 2018-09-18 Rigel Pharmaceuticals, Inc. Small molecule inhibitors of spleen tyrosine kinase (syk)
KR101116756B1 (ko) * 2009-10-27 2012-03-13 한국과학기술연구원 단백질 키나아제 저해활성을 갖는 신규의 1,6-치환된 인돌 화합물
CA2862163A1 (en) * 2012-01-25 2013-08-01 Bayer Pharma Aktiengesellschaft Substituted phenylimidazopyrazoles and use thereof

Also Published As

Publication number Publication date
WO2013110590A1 (de) 2013-08-01
GT201400161A (es) 2015-03-05
IL233652A0 (en) 2014-08-31
SG11201404118XA (en) 2014-10-30
ZA201405392B (en) 2015-12-23
US20130190290A1 (en) 2013-07-25
EP2807162B1 (de) 2017-06-07
ECSP14010868A (es) 2015-12-31
CA2862163A1 (en) 2013-08-01
EA201491427A1 (ru) 2015-01-30
TN2014000320A1 (en) 2015-12-21
US20150005288A1 (en) 2015-01-01
UY34590A (es) 2013-09-02
CL2014001959A1 (es) 2014-11-07
DOP2014000173A (es) 2014-08-31
TW201343649A (zh) 2013-11-01
MA35877B1 (fr) 2014-12-01
EP2807162A1 (de) 2014-12-03
BR112014018450A8 (pt) 2017-07-11
AU2013211707A1 (en) 2014-08-07
PE20142421A1 (es) 2015-01-11
CU20140096A7 (es) 2015-02-26
JP6101290B2 (ja) 2017-03-22
KR20140117582A (ko) 2014-10-07
PH12014501687A1 (en) 2014-10-20
CO7101244A2 (es) 2014-10-31
AP2014007869A0 (en) 2014-08-31
US9394309B2 (en) 2016-07-19
BR112014018450A2 (enExample) 2017-06-20
HK1203198A1 (en) 2015-10-23
MX2014008893A (es) 2014-08-26
JP2015504904A (ja) 2015-02-16
CN104411707A (zh) 2015-03-11
CN104411707B (zh) 2017-03-01
AR089788A1 (es) 2014-09-17
ES2639338T3 (es) 2017-10-26

Similar Documents

Publication Publication Date Title
IL269045A (en) Aptamers and uses thereof
CR20150380A (es) Compuestos de carbamoilpiridona policíclicos y su uso farmacéutico
EP2870505A4 (en) TRANSPARENT GLOSS AND GLOSS PROTECTION STRUCTURES
DK3293183T3 (da) Hæmmerforbindelser
DK2903600T3 (da) Virusholdig formulering og anvendelse deraf
DK2920313T3 (da) Rekombinante adenovira og anvendelse deraf
IL236874A0 (en) Anti-kit antibodies and uses thereof
FI20126017A7 (fi) Kauha ja sen käyttö
CO6930362A2 (es) Compuesto heterocíclico y su uso
DK2864426T3 (da) Justerbare materialer
EP2661839A4 (en) SAFE PORTABLE ELEMENT
EP4144845C0 (en) ANTISENSE COMPOUNDS AND THEIR USES
IL238227A0 (en) Anti-c16orf54 antibodies and methods of use thereof
DK2664816T3 (da) Teleskoperende stræber
CO7000747A2 (es) Anticuerpos anti-lrp5 y métodos de uso
BR112014000049A2 (pt) pirrolotriazinas substituídas com hidroximelilarilo e sua utilização
HRP20182046T1 (hr) Uređaj za kuhanje i postupak njegove upotrebe
DK3038654T3 (da) Ny anvendelse
EP2880400A4 (en) INCLINATION INDICATOR
FI20116089L (fi) Järjestely ja laite
DK3326642T3 (da) Langtidsvirkende koagulationsfaktorer og brugen deraf
DK2917181T3 (da) Heteroarylderivater og anvendelser deraf
CO6781486A2 (es) Compuestos y su uso
NL301064I2 (nl) toltrazuril en gleptoferron
DK2943460T3 (da) 6-chlor-3-(phenyl-d5)-inden-1-on og anvendelse deraf